GI DYNAMICS, INC. | Sales 2019 | - | Sales 2020 | - | Capitalization | 440K 674K 36.73M |
|---|---|---|---|---|---|
| Net income 2019 | -17M -26.03M -1.42B | Net income 2020 | -11M -16.84M -917M | EV / Sales 2019 | - |
| Net Debt 2019 | 2.89M 4.42M 241M | Net Debt 2020 | 2.84M 4.35M 237M | EV / Sales 2020 | - |
| P/E ratio 2019 |
-1.12
x | P/E ratio 2020 |
-0.03
x | Employees | - |
| Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 0% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Joseph Virgilio
CEO | Chief Executive Officer | - | 08/20/08 |
Stephen Linhares
CTO | Chief Tech/Sci/R&D Officer | 67 | 04/19/04 |
Kevin Sarney
TRE | Treasurer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 65 | 10/20/10 | |
Joseph Virgilio
CEO | Chief Executive Officer | - | 08/20/08 |
Ginger Glaser
BRD | Director/Board Member | - | 20/20/20 |
GI Dynamics, Inc. is a medical device company. The Company designs and applies device and disease management solutions for the treatment of metabolic disease. The Company designs, develops, manufactures and markets medical devices for non-surgical approaches to treat type II diabetes and obesity. The Company's product, EndoBarrier, is an endoscopically-delivered device therapy, which is approved for the treatment of obese type II diabetes with body mass index (BMI) greater than or equal to 30 kilogram/square meter (kg/m2), or obese patients with BMI greater than or equal to 30 kg/m2 with greater than or equal to one comorbidities, or obese patients with BMI over 35 kg/m2. EndoBarrier is an incision-free, non-anatomy altering solution designed to specifically mimic the duodenal-jejunal exclusion created by gastric bypass surgery.
Sector
-
